Quinupristin (BioDeep_00000855497)

Main id: BioDeep_00000006647

 


代谢物信息卡片


N-[(3S,6S,12R,15S,16R,19S)-25-[[(3S)-1-Azabicyclo[2.2.2]octan-3-yl]sulfanylmethyl]-3-[[4-(dimethylamino)phenyl]methyl]-12-ethyl-4,16-dimethyl-2,5,11,14,18,21,24-heptaoxo-19-phenyl-17-oxa-1,4,10,13,20-pentazatricyclo[20.4.0.06,10]hexacosan-15-yl]-3-hydroxypyridine-2-carboxamide

化学式: C53H67N9O10S (1021.4731)
中文名称: 奎奴普丁
谱图信息: 最多检出来源 () 0%

分子结构信息

SMILES: CCC1C(=O)N2CCCC2C(=O)N(C(C(=O)N3CC(C(=O)CC3C(=O)NC(C(=O)OC(C(C(=O)N1)NC(=O)C4=C(C=CC=N4)O)C)C5=CC=CC=C5)CSC6CN7CCC6CC7)CC8=CC=C(C=C8)N(C)C)C
InChI: InChI=1S/C53H67N9O10S/c1-6-37-50(68)61-23-11-14-38(61)51(69)59(5)40(26-32-16-18-36(19-17-32)58(3)4)52(70)62-28-35(30-73-43-29-60-24-20-33(43)21-25-60)42(64)27-39(62)47(65)57-45(34-12-8-7-9-13-34)53(71)72-31(2)44(48(66)55-37)56-49(67)46-41(63)15-10-22-54-46/h7-10,12-13,15-19,22,31,33,35,37-40,43-45,63H,6,11,14,20-21,23-30H2,1-5H3,(H,55,66)(H,56,67)(H,57,65)/t31-,35+,37-,38+,39+,40+,43-,44+,45+/m1/s1

描述信息

D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D025361 - Streptogramins
C254 - Anti-Infective Agent > C258 - Antibiotic
Quinupristin is a streptogramin antibiotic. Quinupristin blocks peptide bond synthesis to prevent the extension of polypeptide chains and promote the detachment of incomplete protein chains in the bacterial ribosomal subunits[1] [2].

同义名列表

3 个代谢物同义名

N-[(3S,6S,12R,15S,16R,19S)-25-[[(3S)-1-Azabicyclo[2.2.2]octan-3-yl]sulfanylmethyl]-3-[[4-(dimethylamino)phenyl]methyl]-12-ethyl-4,16-dimethyl-2,5,11,14,18,21,24-heptaoxo-19-phenyl-17-oxa-1,4,10,13,20-pentazatricyclo[20.4.0.06,10]hexacosan-15-yl]-3-hydroxypyridine-2-carboxamide; Quinupristin; Quinupristin



数据库引用编号

13 个数据库交叉引用编号

分类词条

相关代谢途径

Reactome(0)

BioCyc(0)

PlantCyc(0)

代谢反应

0 个相关的代谢反应过程信息。

Reactome(0)

BioCyc(0)

WikiPathways(0)

Plant Reactome(0)

INOH(0)

PlantCyc(0)

COVID-19 Disease Map(0)

PathBank(0)

PharmGKB(0)

0 个相关的物种来源信息

在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有:

  • PubMed: 来源于PubMed文献库中的文献信息,我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表,这个列表按照代谢物同时出现的文献数量降序排序,取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
  • NCBI Taxonomy: 通过文献数据挖掘,得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序,取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
  • Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
  • Chemical Reaction: 在化学反应过程中,存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。

点击图上的相关代谢物的名称,可以跳转到相关代谢物的信息页面。

亚细胞结构定位 关联基因列表
Cytoplasm 9 BLNK, CDK2AP1, MEFV, MSRA, RB1CC1, RPL22, RPL3, RPL4, SCGB1A1
Peripheral membrane protein 1 ATP6V1D
Endosome membrane 1 ATP6V1D
Endoplasmic reticulum membrane 1 RB1CC1
Cytoplasmic vesicle, autophagosome 1 MEFV
Nucleus 7 CDK2AP1, MEFV, PRPF8, RB1CC1, RPL22, RPL3, RPL4
autophagosome 1 MEFV
cytosol 10 ATP6V1D, BLNK, CDK2AP1, MEFV, MSRA, PRF1, RB1CC1, RPL22, RPL3, RPL4
dendrite 1 ACVRL1
centrosome 1 ATP6V1D
nucleoplasm 5 ATP6V1D, CDK2AP1, MEFV, MSRA, PRPF8
Cell membrane 4 ACVRL1, BLNK, PRF1, TNF
Lipid-anchor 1 MSRA
Cytoplasmic side 1 ATP6V1D
lamellipodium 1 MEFV
Multi-pass membrane protein 1 PRF1
cell surface 2 ACVRL1, TNF
glutamatergic synapse 1 RPL22
Golgi apparatus 1 FUT2
Golgi membrane 2 ATP6V1D, FUT2
lysosomal membrane 1 ATP6V1D
neuronal cell body 2 ACVRL1, TNF
Cytoplasm, cytosol 1 RB1CC1
Lysosome 1 RB1CC1
Presynapse 1 RPL22
plasma membrane 7 ACVRL1, ATP6V1D, BLNK, F2, MSRA, PRF1, TNF
Membrane 7 ACVRL1, ATP6V1D, BLNK, MSRA, PRF1, PRPF8, RPL4
extracellular exosome 9 ATP6V1D, DEFA1, F2, FUT2, MSRA, RPL22, RPL3, RPL4, SCGB1A1
extracellular space 6 CXCL8, DEFA1, F2, IL10, SCGB1A1, TNF
perinuclear region of cytoplasm 1 CDK2AP1
mitochondrion 1 MSRA
protein-containing complex 1 RPL3
intracellular membrane-bounded organelle 2 BLNK, MSRA
Single-pass type I membrane protein 1 ACVRL1
Secreted 5 CXCL8, F2, IL10, PRF1, SCGB1A1
extracellular region 7 CXCL8, DEFA1, F2, IL10, PRF1, SCGB1A1, TNF
Cell projection, cilium 1 ATP6V1D
Cytoplasm, cytoskeleton, microtubule organizing center, centrosome 1 ATP6V1D
nuclear membrane 1 RB1CC1
external side of plasma membrane 1 TNF
actin cytoskeleton 1 MSRA
cytoplasmic vesicle 1 MEFV
nucleolus 2 RPL3, RPL4
Cytoplasmic vesicle, clathrin-coated vesicle membrane 1 ATP6V1D
clathrin-coated vesicle membrane 1 ATP6V1D
midbody 1 MSRA
recycling endosome 1 TNF
Single-pass type II membrane protein 2 FUT2, TNF
Cell projection, lamellipodium 1 MEFV
Membrane raft 1 TNF
focal adhesion 3 RPL22, RPL3, RPL4
microtubule 1 MEFV
collagen-containing extracellular matrix 2 DEFA1, F2
secretory granule 1 SCGB1A1
nuclear speck 1 PRPF8
Cell projection, ruffle 1 MEFV
ruffle 1 MEFV
cilium 1 ATP6V1D
chromatin 1 CDK2AP1
microtubule associated complex 1 MEFV
autophagosome membrane 1 RB1CC1
phagocytic cup 1 TNF
Chromosome 1 CDK2AP1
Nucleus, nucleolus 1 RPL3
blood microparticle 1 F2
spliceosomal complex 1 PRPF8
nuclear envelope 1 SCGB1A1
endosome lumen 1 PRF1
phagophore assembly site 1 RB1CC1
phagophore assembly site membrane 1 RB1CC1
specific granule membrane 1 ATP6V1D
Golgi cisterna membrane 1 FUT2
Nucleus speckle 1 PRPF8
Golgi lumen 2 DEFA1, F2
endoplasmic reticulum lumen 1 F2
extrinsic component of synaptic vesicle membrane 1 ATP6V1D
azurophil granule lumen 1 DEFA1
Golgi apparatus, Golgi stack membrane 1 FUT2
NuRD complex 1 CDK2AP1
immunological synapse 1 PRF1
ribonucleoprotein complex 3 RPL22, RPL3, RPL4
[Isoform 2]: Nucleus 1 MEFV
U2-type catalytic step 1 spliceosome 1 PRPF8
U2-type precatalytic spliceosome 1 PRPF8
[Isoform 1]: Cytoplasm, cytoskeleton 1 MEFV
canonical inflammasome complex 1 MEFV
U4/U6 x U5 tri-snRNP complex 1 PRPF8
catalytic step 2 spliceosome 1 PRPF8
Rough endoplasmic reticulum 1 RPL4
U2-type catalytic step 2 spliceosome 1 PRPF8
cytosolic ribosome 3 RPL22, RPL3, RPL4
Preautophagosomal structure 1 RB1CC1
Atg1/ULK1 kinase complex 1 RB1CC1
vacuolar proton-transporting V-type ATPase, V1 domain 1 ATP6V1D
U5 snRNP 1 PRPF8
proton-transporting V-type ATPase complex 1 ATP6V1D
ribosome 3 RPL22, RPL3, RPL4
[Tumor necrosis factor, soluble form]: Secreted 1 TNF
cytosolic large ribosomal subunit 3 RPL22, RPL3, RPL4
Cytolytic granule 1 PRF1
cytolytic granule lumen 1 PRF1
BMP receptor complex 1 ACVRL1
[C-domain 2]: Secreted 1 TNF
[Tumor necrosis factor, membrane form]: Membrane 1 TNF
[C-domain 1]: Secreted 1 TNF


文献列表

  • Rudramani Pokhrel, Prem Chapagain, Jessica Siltberg-Liberles. Potential RNA-dependent RNA polymerase inhibitors as prospective therapeutics against SARS-CoV-2. Journal of medical microbiology. 2020 Jun; 69(6):864-873. doi: 10.1099/jmm.0.001203. [PMID: 32469301]
  • R Scott Obach, Franco Lombardo, Nigel J Waters. Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals. 2008 Jul; 36(7):1385-405. doi: 10.1124/dmd.108.020479. [PMID: 18426954]
  • L Drago, L Nicola, E De Vecchi. A comparative in-vitro evaluation of resistance selection after exposure to teicoplanin, vancomycin, linezolid and quinupristin-dalfopristin in Staphylococcus aureus and Enterococcus spp. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 2008 Jun; 14(6):608-11. doi: 10.1111/j.1469-0691.2008.01993.x. [PMID: 18397336]
  • A Chaudhury, A G Kumar. In vitro activity of antimicrobial agents against oxacillin resistant staphylococci with special reference to Staphylococcus haemolyticus. Indian journal of medical microbiology. 2007 Jan; 25(1):50-2. doi: 10.4103/0255-0857.31062. [PMID: 17377353]
  • Thomas G Fraser, Christine Hansen, Jennifer K Long. Newer antibiotics for serious gram-positive infections. Cleveland Clinic journal of medicine. 2006 Sep; 73(9):847-53. doi: 10.3949/ccjm.73.9.847. [PMID: 16970136]
  • Robert L Thompson, Bruce Lavin, George H Talbot. Endocarditis due to vancomycin-resistant Enterococcus faecium in an immunocompromised patient: cure by administering combination therapy with quinupristin/dalfopristin and high-dose ampicillin. Southern medical journal. 2003 Aug; 96(8):818-20. doi: 10.1097/01.smj.0000047962.61701.57. [PMID: 14515928]
  • V Schwenger, E Mündlein, E E Dagrosa, A M Fahr, M Zeier, G Mikus, K Andrassy. Treatment of life-threatening multiresistant staphylococcal and enterococcal infections in patients with end-stage renal failure with quinupristin/dalfopristin: preliminary report. Infection. 2002 Oct; 30(5):257-61. doi: 10.1007/s15010-002-2076-3. [PMID: 12382082]
  • P D Walzer, A Ashbaugh, M Collins, M T Cushion. In vitro and in vivo effects of quinupristin-dalfopristin against Pneumocystis carinii. Antimicrobial agents and chemotherapy. 2001 Nov; 45(11):3234-7. doi: 10.1128/aac.45.11.3234-3237.2001. [PMID: 11600389]
  • L C McDonald, S Rossiter, C Mackinson, Y Y Wang, S Johnson, M Sullivan, R Sokolow, E DeBess, L Gilbert, J A Benson, B Hill, F J Angulo. Quinupristin-dalfopristin-resistant Enterococcus faecium on chicken and in human stool specimens. The New England journal of medicine. 2001 Oct; 345(16):1155-60. doi: 10.1056/nejmoa010805. [PMID: 11642231]
  • D R Allington, M P Rivey. Quinupristin/dalfopristin: a therapeutic review. Clinical therapeutics. 2001 Jan; 23(1):24-44. doi: 10.1016/s0149-2918(01)80028-x. [PMID: 11219478]
  • P Chevalier, J Rey, O Pasquier, V Leclerc, J C Baguet, A Meyrier, N Harding, G Montay. Pharmacokinetics of quinupristin/ dalfopristin in patients with severe chronic renal insufficiency. Clinical pharmacokinetics. 2000 Jul; 39(1):77-84. doi: 10.2165/00003088-200039010-00005. [PMID: 10926351]
  • G Werner, I Klare, H Heier, K H Hinz, G Böhme, M Wendt, W Witte. Quinupristin/dalfopristin-resistant enterococci of the satA (vatD) and satG (vatE) genotypes from different ecological origins in Germany. Microbial drug resistance (Larchmont, N.Y.). 2000; 6(1):37-47. doi: 10.1089/mdr.2000.6.37. [PMID: 10868806]
  • H M Lamb, D P Figgitt, D Faulds. Quinupristin/dalfopristin: a review of its use in the management of serious gram-positive infections. Drugs. 1999 Dec; 58(6):1061-97. doi: 10.2165/00003495-199958060-00008. [PMID: 10651391]
  • B M Lomaestro, L L Briceland. Streptogramins and their potential role in geriatric medicine. Drugs & aging. 1998 Dec; 13(6):443-65. doi: 10.2165/00002512-199813060-00004. [PMID: 9883400]
  • A Le Liboux, O Pasquier, G Montay. Simultaneous high-performance liquid chromatographic determination of quinupristin, dalfopristin and their main metabolites in human plasma. Journal of chromatography. B, Biomedical sciences and applications. 1998 Apr; 708(1-2):161-8. doi: 10.1016/s0378-4347(98)00005-x. [PMID: 9653958]